The Scope of Things
Episodes
51 episodes
Episode: 50 - Ramona Burress and Cassandra O’Neal on Health Equity That Works
Health equity is being reorganized, renamed, or quietly deprioritized. Ramona Burress, co-founder of Onyx Health Collective, and Cassandra O’Neal, founder of Illuminated Arc Consulting, join the Scope of Things podcast for a direct, practical c...
Episode: 49 - Mike Sullivan on AI and Clinical Operations in the Year 2030
What will AI and clinical trials look like in the year 2030? Mike Sullivan, head of IT globally for development operations at Bristol Myers Squibb, joins The Scope of Things to discuss how creating value with AI depends on redesigning how clini...
Episode: 48 - Florence Mowlem on the Challenges and Solutions of Pediatric Rare Disease Trials
How can electronic capture of clinical outcome assessments (eCOA) help with the unique challenges of pediatric rare disease trials? Florence Mowlem, chief scientific officer of uMotif, joins The Scope of Things to offer her expertise on eCOA, s...
Episode: 47 - Joseph Kim on Pragmatic Solutions to Age-Old Problems
Joining this month’s episode of The Scope of Things is Joseph Kim, chief strategy officer of ProofPilot, who talks about his company’s first-ever CORE Symposium, where pharma pros shared practical solutions to age-old trial challenges. Kim prov...
Episode: 46 - Dan Drozd on How Noninterventional Studies Can Change the Clinical Research Game
Noninterventional studies in clinical research are underutilized in clinical research and inefficient. Dan Drozd, CMO of PicnicHealth, knows we can do better. With host Deborah Borfitz, Drozd discusses the issues and ramifications researchers f...
Episode: 45 - Doug Bain on Streamlining Clinical Trials
Doug Bain, founder and consulting partner of ClinFlo, discusses his proposed regulatory blueprint for digital trials in the latest episode of The Scope of Things podcast. With host Deborah Borfitz, Bain delves into his strategy for turning 21 C...
Episode 44 - SCOPE Europe 2025 on AI Literacy Training, Reducing Excess Data Collection, Combating Superbugs
This episode of the Scope of Things features an exclusive panel at SCOPE Europe 2025 covering regulatory requirements for AI literacy training, featuring industry executives Jonathan Crowther, head of the operational design center at Merck KGaA...
Episode: 43 - Overcoming the Deadlock in Patient Recruitment With Christine Senn
For decades, clinical trial recruitment has been the biggest challenge in the industry. Christine Senn, senior vice president of Site-Sponsor Innovation at Advarra, offers insights into why the struggle continues, such as delays in getting regu...
Episode: 42 - Myeloma Research on a Global Scale with Joseph Mikhael
Joseph Mikhael, chief medical officer of The International Myeloma Foundation, and his organization are pulling all the stops to find a true cure for multiple myeloma, a rare and often fatal blood cancer. He shares the origins and mission of th...
Episode: 41 - How Non-Profits Are Filling Unique Roles in Clinical Research
Children’s Tumor Foundation CEO Annette Bakker discusses what non-profit organizations uniquely bring to clinical research and new financial models sustaining their contribution. Plus, host Deborah Borfitz rounds up the latest news in clinical ...
Episode 40: The Advancement and Implementation of Pragmatic Trials
The latest on a trio of pragmatic trials for lung cancer treatment, the implementation of national-scale pharmacogenomic testing, an efficient approach to comparing commonly used intravenous fluids, improving access to gene therapy trials for a...
Episode: 39 - Blythe Adamson on Patient-Level Real-World Data for Multinational Oncology Research
In this episode of the Scope of Things, host Deborah Borfitz brings you the latest news on AI-recommended precision dosing, organoid drug testing aiding treatment selection for bowel cancer, an AI tool for stratifying lung cancer patients, usin...
Episode: 38 - Tackling the Misinformation Epidemic with Briony
In this episode of the Scope of Things, host Deborah Borfitz brings you the news on a precision medicine initiative in Sweden integrating research with healthcare, newly available cardiometabolic clinical data registries for real world evidence...
Episode: 37 - Using AI to Translate Clinical Trial Results with Ravi Parikh
In this episode of The Scope of Things, host Deborah Borfitz covers the latest news, including setting expectations for Phase II cancer trials, key learnings about dementia from the Nun Study, links between cardiovascular disease and mild cogni...
Episode: 36 - Wes Michael on Enhancing Patient Voices and Sharing Their Insights
In this episode of the Scope of Things, host Deborah Borfitz delivers the latest on an AI-powered trial screening tool that outperforms research staff, a strategy report on ways to boost cancer vaccine work, the continued absence of pregnant wo...
Episode: 35 - SCOPE 2025, Participant Engagement Award Winners, How AI is Helping Trials, and More
In this episode of the Scope of Things, host Deborah Borfitz provides the latest on new criteria for defining and diagnosing obesity, the case for including pregnant women in vaccine trials, the subtyping of osteosarcoma, an inert gas being tes...
.png)
Episode: 34 - Ringing in 2025 With Validating Novel Digital Clinical Measures, Decentralized Trials, and More
In this episode of the Scope of Things, host Deborah Borfitz delivers the news on an investigation into data reporting problems in major Ticagrelor clinical trial PLATO, the need for more sex-aware cancer research, Alzheimer’s studies looking a...
Episode:33 - Orr Inbar Discusses Saving Costs and Complications With Clinical Trial Simulations
In this episode of the Scope of Things, host Deborah Borfitz covers concerns surrounding the study and treatment of obesity, a new “opening doors” initiative to clinical trials, debate over the European Union AI Act, the first international-lev...
Episode: 32 - SCOPE Europe 2024, AI, New Cancer Treatments, More
In this episode of the Scope of Things, host Deborah Borfitz shares the latest news on a drug repurposing AI model now being tested in rare disease clinical trials, a new way forward for triple-negative breast cancer, Jill Pellegrino’s transiti...
Episode: 31 - Aaron Mackey on Trial Planning and How AI Can Help With Diversity
Tune in for the latest news and trends in this month’s episode of the Scope of Things, where host Deborah Borfitz covers everything you need to know about a pending launch of a large treatment trial for Graves’ disease, a recruitment campaign f...
Episode: 30 - Shining the Spotlight on Rare Disease Trials With Uncommon Cures
This month’s episode of The Scope of Things features the latest trending news from host Deborah Borfitz, including a planned library of “nature’s drugs” targeting complex diseases, a paradoxical approach to treating cancer, how government polic...
Episode 29 - Patient-Focused Drug Design, Enrollment Challenges, and More With Hannah Kemp
Tune into this month’s episode of the Scope of Things, where host Deborah Borfitz covers the use of AI for trial screening and recruitment purposes, a diabetes drug that may help treat sleep apnea, questionable advice from the FDA given to depa...
Episode: 28 - Jonathan Kimmelman on Research Ethics and Dilemmas in Clinical Trials
In this month’s episode of the Scope of Things, host Deborah Borfitz gives you the latest news on the fallacy of a survival benefit for cancer patients participating in clinical trials, how and why federally qualified health centers are getting...
Episode: 27 - Yvonne Rodriguez on Making Clinical Trials Accessible for Everyone
In this episode of the Scope of Things, host Deborah Borfitz covers the latest news on an AI model for comparing drug effectiveness, adoption of minimal residual disease as an endpoint for multiple myeloma, using HIV treatments for Alzheimer’s ...
Episode: 26 - Digital Twins, Care-For-All European Platform, and the Impact and Future of Wearables and Microsampling
In this episode of the Scope of Things, host Deborah Borfitz brings you the monthly breakdown on current events, such as tailoring medications to individual patients using digital twins, the use of a skin biopsy test to diagnose neurodegenerati...
